✦ LIBER ✦

Evaluation of a New Saliva Collection Device for HIV Antibody Screening Purposes

✍ Scribed by C. Gómez; M. Gutiérrez; P. Martínez-Acacio; V. Soriano

Book ID: 115110048
Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 151 KB
Volume: 66
Category: Article
ISSN: 0042-9007
DOI: 10.1111/j.1423-0410.1994.tb00319.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A New Device for Collection of Parotid S

A New Device for Collection of Parotid Saliva

✍ THORILD ERICSON; ÅKE NORDLUND 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

A new generation of serum anti-HIV antib

A new generation of serum anti-HIV antibody immunocapture assay for saliva testing

✍ Pasquier, C.; Bello, P.-Y.; Gourney, P.; Puel, J.; Izopet, J. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Evaluation of the Q.E.D.™ saliva alcohol

Evaluation of the Q.E.D.™ saliva alcohol test: A new, rapid, accurate device for measuring ethanol in saliva

✍ Theodore A Christopher; Joseph A Zeccardi 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Evaluation of a dried plasma collection

Evaluation of a dried plasma collection device for the detection of H. Pylori antibodies

✍ E.H. Cheng; K. Ashraf; M. Roeske; F. Rubenbauer; R. Shaw; P. Marchildon; J. Peac 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Evaluation of a new Trypanosoma cruzi an

Evaluation of a new Trypanosoma cruzi antibody assay for blood donor screening

✍ Jed Gorlin; Susan Rossmann; Gene Robertson; Fred Stallone; Nora Hirschler; Kim-A 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Evaluation of a new screening assay for

Evaluation of a new screening assay for HTLV-1 and -2 antibodies for large-scale use

✍ Kerstin Malm; Torbjörn Kjerstadius; Sören Andersson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Abstract Laboratory testing for Human T‐lymphotropic Virus type 1 and 2 (HTLV‐1 and ‐2) infections has become routine in blood transfusion, tissue transplantation and clinical diagnoses in many countries worldwide. Screening is usually based on the detection of antibodies to HTLV‐1 and/ or ‐2. T